CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 64,550	$ 47,529
General and administrative	28,868	21,489
Total operating expenses	93,418	69,018
Loss from operations	(93,418)	(69,018)
Other income:
Interest income	1,324	119
Total other income	1,324	119
Net loss	(92,094)	(68,899)
Cumulative dividends on redeemable convertible preferred stock		(1,228)
Net loss attributable to common stockholders	$ (92,094)	$ (70,127)
Net loss per share attributable to common stockholders, basic	$ (2.33)	$ (2.10)
Net loss per share attributable to common stockholders, diluted	$ (2.33)	$ (2.10)
Weighted-average number of common shares outstanding, basic	39,551,420	33,433,214
Weighted-average number of common shares outstanding, diluted	39,551,420	33,433,214
Other comprehensive loss:
Unrealized gain (loss) on available for sale investments	$ (770)
Total other comprehensive loss	(770)
Comprehensive loss attributable to common stockholders	$ (92,864)	$ (70,127)